This federal Project Grant award from the National Institute of Mental Health (NIMH), under CFDA Program 93.242 Mental Health Research Grants, is for $765,622 to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The primary purpose of the grant is to conduct a 3-arm randomized controlled trial to test the effectiveness of two adherence support strategies - personalized daily text message reminders, with and without financial...
The National Institute of Mental Health (NIMH) awarded a Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the University of California, Los Angeles (UCLA) to implement a cluster randomized control trial (CRCT) testing the impact of a long-term, dynamic choice intervention on 12-month viral suppression for HIV treatment interruption clients in Malawi. The $653,677 grant, awarded on April 1, 2025, with an ultimate completion date of January 31, 2030, will support...
This $469,291 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports a study to improve HIV care outcomes through a hybrid implementation-effectiveness trial. The key products and services to be delivered include: Examining the effectiveness of an algorithm-driven Comprehensive Care Management and Care Coordination (CCM/CC) implementation strategy on improving HIV-related outcomes like emergency department...
The National Institute of Mental Health (NIMH) awarded a Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Research Triangle Institute (RTI International) for $710,187 to implement the "CARES: AN ADHERENCE SUPPORT INTERVENTION FOR MULTIPLE PREP METHODS AMONG ADOLESCENT GIRLS AND YOUNG WOMEN IN SOUTH AFRICA AND ZIMBABWE" project. The goal is to adapt and evaluate the effectiveness, feasibility, and acceptability of the CARES intervention to support...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $1,243,071 to Groupware Technologies, LLC to develop a web-based collaborative eligibility, enrollment, and AIDS Drug Assistance Program (ADAP) management platform. The key objectives are to: 1) Create a more functional and usable system for determining eligibility and accessing Ryan White HIV/AIDS Program (RWHAP) services; 2) Validate a decrease...
The National Institute of Mental Health (NIMH) awarded a $389,880 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the University of North Carolina at Chapel Hill (UNC-CH) to develop and test behavioral economics and financial incentive-based strategies to improve treatment engagement, medication adherence, and substance avoidance for patients transitioning from Coordinated Specialty Care (CSC) for first-episode psychosis to post-CSC care. This 5-year grant (award date: September...
This federal Project Grant award for $729,367, awarded on December 18, 2024 by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), will support research to assess the impacts of a 2022 nationwide shortage of immediate-release amphetamine mixed salts prescription stimulant medications on the health and treatment outcomes of youth with Attention-Deficit Hyperactivity Disorder (ADHD). The research team from the Rand Corporation will: 1)...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $1,364,940 to the Regents of the University of Minnesota to conduct a cluster randomized controlled trial investigating methods to measure and reduce HIV stigma in healthcare settings. The key products and services to be delivered include: Baseline standardized patient visits to healthcare clinics to assess enacted HIV, sexual, and intersectional...
This $1,325,208 Project Grant award from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) supports a comprehensive research study to evaluate sequential strategies for returning and re-engaging individuals with HIV treatment lapses in Zambia. The primary objective is to assess the effectiveness and cost-effectiveness of combinations of navigation services and community-based medication delivery to improve viral suppression rates. The study will recruit...
The federal Project Grant award K01MH138243, titled "REDUCING MOBILITY-ASSOCIATED INTERRUPTION IN ART AMONG MEN IN MALAWI (REMIT)", is funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The $183,179 award, effective September 1, 2024, supports a 5-year research project to refine and pilot an intervention to improve antiretroviral treatment (ART) outcomes among mobile men living with HIV in Malawi. The project,...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $998,850.00 to The RAND Corporation to conduct the "Incentives and Reminders to Improve Long-Term Medication Adherence (INMIND)" research project. The project aims to identify optimal sequencing of low-resource reminder messages and higher-resource incentive prizes to cost-effectively promote long-term antiretroviral therapy (ART) adherence among people living with HIV. A key aspect involves testing the effectiveness of anchoring ART adherence to existing daily routines, augmented by either reminder messages or incentive prizes. The project will utilize a Sequential, Multiple Assignment, Randomized Trial (SMART) design to evaluate the impact of these intervention components on maintaining ART adherence and viral suppression. A sub-award of $721,000 was made to Arizona State University to support the research. The project period runs from Sep 1, 2024 to Aug 31, 2029.